Splenic lymphocytes from preleukemic AKR mice are capable of participating in various cell-mediated immune responses. Spleen cells from AKR mice aged 1 to 10 months produced a significant graft-versus-host reaction when injected into 8-day-old AKR x C57BV/6 F, hybrids. Splenic lymphocytes from similarly aged mice were also capable of responding to allogenic stimulation in a mixed lymphocyte reaction. AKR mice aged 1 to 10 months developed a contact sensitivity response to picryl chloride. It was concluded that mice of this high-leukemic strain have a competent cell-mediated immune system and there is no depression of immunity during the preleukemic period.
Depression of cell-mediated immunity may be associated with the expression of cancer. The increased occurrence of malignancies in both man and laboratory animals after immunosuppressive therapy lends support to this hypothesis (16) . Furthermore, infection of susceptible mice with Friend leukemia virus results in the depression of cell-mediated immunity prior to the onset of malignancy (6, 13) . However, in strains of mice which develop spontaneous lymphoid leukemia, such as the AKR strain, there are conflicting reports on the cellmediated immune capacity during the preleukemic period. Female AKR mice were shown to have a decreased ability to reject syngeneic male skin as compared to C57Bl/6 mice (3). Migration inhibition factor production was shown to be impaired throughout the life span of AKR mice (5), and AKR spleen cells exhibited a reduced ability to induce a graft-versushost reaction (GVHR) (9) . On the other hand, AKR mice were shown to be capable of rejecting allografted lymphoma cells (8) , sarcoma 180 (4), and allografted skin from mice of the same sex (10). Hargis and Malkiel (7) reported spleen cells from 1-to 11-month-old AKR mice were capable of inducing a GVHR in newbom CFW mice. In the present investigation, the cellular immunocapacity of preleukemic AKR mice was studied to ascertain if a depression in cellmediated immunity was a necessary prerequisite for the onset of the disease. The in vivo models of cellular immunity, GVHR and contact sensitivity, were utilized as was the in vitro correlate of GVHR, the mixed leukocyte reaction (MLR).
MATERIALS AND METHODS
Animals. AKR and C57BV/6 were originally obtained from the Jackson Laboratory, Bar Harbor, Me., and subsequently maintained in this laboratory by strict brother-sister mating. The incidence of generalized lymphoma was 87% in AKR mice with the average age of death 9.4 months. All mice were fed Wayne sterilizable Lab-Blox and water ad libitum.
GVH reaction. Donor mice were sacrificed and spleens were removed aseptically. Single-cell suspensions were prepared by passing the spleens through a 100-mesh stainless-steel wire screen into cold medium 199 (M199) with Earle modified salts (GIBCO, Grand Island, N.Y.). The cells were washed three times with cold M199 and collected each time by low-speed centrifugation. A total leukocyte count was performed by employing a hemocytometer, and viability was determined by trypan blue exclusion. Eight-day-old AKR x C57BV/6 F, (AKB6F,) mice were injected intraperitoneally with various concentrations of viable spleen cells in 0.1 ml of M199 (Fig. 1) . Since an inoculum of 10 x 106 viable spleen cells elicited splenic indexes greater than two, this cell concentration was used throughout. In all experiments at least two uninjected litter mates served as controls. Eight days postinjection, the spleen weight assay for GVH reactivity was performed by the method of Simonsen and Jensen (15) . A splenic index of greater than 1.3 is considered positive.
MLR. Donor mice were sacrificed and the spleens were removed aseptically. Single-cell suspensions were prepared as before. Stimulator cells were obtained by treatment with mitomycin C (MC) (Nutri- Contact sensitivity. A modification of the technique of Asherson and Ptak (1) was used for determining contact sensitivity in AKR mice aged 1, 3, 5, 7, and 10 months. The mice were anesthesized with sodium pentobarbital, the abdomen was shaved, and they were immunized by painting 0. These donor cells were from animals aged 1, 3, 5, 7, and 10 months of age. All AKR donor cells were from animals which showed no gross signs of leukemia, absence of thymus and lymph node enlargement and splenomegaly, at the time of spleen cell isolation. Figure 2 illustrates the results of GVHR induced by either AKR or C57Bl/6 spleen cells. AKR splenic lymphocytes at all ages tested were capable of inducing a significant GVHR (>1.3) in F, recipients. The ability of AKR spleen cells to mount a GVHR increased from 1 to 5 months, peaked at 5 to 7 months, and decreased to the initial level by 10 months of age. When C57BI/6 spleen cells were employed to induce a GVHR, the response curve was similar to that seen with AKR cells. However, the magnitude of the C57BI/6 response was higher than the AKR response.
MLR. One-way mixed leukocyte reactions were used as an in vitro correlate of the GVHR. Table 1 response remained at about the same level at all ages tested.
DISCUSSION
Control of aberrant cells and resulting malignancies has been attributed to the immunologic surveillance system (2) . Deficiencies in the surveillance mechanism whether natural or artificial (16) lead to an increased incidence of de on August 27, 2017 by guest http://iai.asm.org/ Downloaded from novo tumors. Experimentation utilizing passaged leukemia viruses has also supported this concept. Susceptible mice infected with Friend leukemia virus exhibited a marked depression of delayed-type hypersensitivity to purified protein derivative (PPD) and depression of migration inhibition factor prior to the onset of leukemia (13) . A similar immune depression was observed following infection with Rauscher leukemia virus in susceptible mice (12) .
To date, however, there is very little data concerning cellular immune competence prior to the onset of spontaneously arising murine leukemias. Mice of the AKR strain naturally harbor vertically transmitted Gross virus and spontaneously develop a lymphoid leukemia of thymic origin. The initial thymoma becomes evident during the preleukemic period (4 to 6 months of age) and usually becomes disseminated (leukemic period), with 85 to 90% of the mice dying by 11 months of age. If a breakdown of the immune surveillance system were a prerequisite for viral-induced cancer in the AKR mouse, it should occur during the preleukemic period. Our experiments, however, have shown that there is no observable decrease in cell-mediated immunity in AKR mice during the preleukemic period.
Spleen cells from AKR donor mice aged 1 to 10 months were able to induce a significant GVHR in AKR x C57BI/6 F, hybrids. Similar results were obtained by Hargis and Malkiel (7) . They showed AKR spleen cells from donors aged 1 through 11 months were capable of inducing a significant GVHR in newbom CFW mice. In contrast, AKR spleen cells produced only marginal GVHR when injected into SJL x AKR F1 hybrids (9) . Also, there was no correlation between the degree of GVHR and varying lymphocyte concentration within this strain combination. This apparent lack of reactivity may be due to the strain combination since AKR cells were able to induce GVHR in AKR x C57Bl/6 F1 hybrids (Fig. 1 ) and in AKR x DBA F1 hybrids (14) . When donor AKR cell concentrations were increased, there was an concomitant increase in splenic index (Fig. 1) The contact sensitivity response to picryl chloride is also a measure of cell-mediated immunity (12) . Mice of the AKR strain aged 1 through 10 months exhibited a significant contact sensitivity response to picryl chloride. The ability of spleen cells from AKR mice aged 7 and 10 months to induce a significant GVHR, MLR, and contact sensitivity response may be due to the-selection of leukemia-resistant mice. The mice from the younger age groups would, on the other hand, have a larger percentage of leukemia-prone animals. Thus, the present data do not support the concept that a depression of cell-mediated immunity (immunological surveillance) is a prerequisite for the preleukemic state in AKR mice. Further experimentation is being conducted to elucidate the interaction of the Gross virus, thymus function, and cell-mediated immunity on the induction of lymphoid leukemia in AKR mice.
